info@thoroughbredbhc.com
Suboxone withdrawal symptoms can feel overwhelming, but knowing what to expect makes the process far less frightening. Most people experience a delayed onset compared with short-acting opioids, with physical symptoms peaking around days three to five and psychological symptoms like depression and cravings often lasting weeks beyond that. This article walks you through the full withdrawal timeline, explains what drives each phase, and covers the most evidence-backed ways to ease symptoms safely.
Suboxone Withdrawal Symptoms: The Full Picture
Suboxone contains two ingredients: buprenorphine and naloxone. Buprenorphine does the heavy lifting. It is a partial opioid agonist that binds tightly to opioid receptors, suppresses cravings, and prevents withdrawal while you are taking it. Naloxone is added mainly to deter misuse by injection and plays little role in the withdrawal experience when Suboxone is taken as prescribed, as buprenorphine pharmacology research confirms.
When you reduce or stop Suboxone, your nervous system has to recalibrate. That recalibration is what produces withdrawal. According to American Addiction Centers, common symptoms include nausea, vomiting, headaches, muscle and body aches, insomnia, lethargy, digestive distress, anxiety, depression, irritability, cravings, fever, chills, and difficulty concentrating.
Physical dependence after long-term opioid receptor activation is expected and is clinically distinct from uncontrolled addiction behavior. Withdrawal is not evidence that treatment failed.
Suboxone Withdrawal Symptoms Timeline: Phase by Phase
One of the most important things to understand about the Suboxone withdrawal symptoms timeline is that it runs longer than withdrawal from short-acting opioids like heroin or oxycodone. Buprenorphine has extremely high receptor affinity and dissociates slowly, which smooths out the withdrawal curve but also stretches it. Research on buprenorphine’s receptor properties shows it can suppress withdrawal for two to three days after the last dose, which explains why many people feel relatively stable on day one only to feel worse later.
Here is a practical phase-by-phase breakdown.
Hours 0 to 24: The Quiet Beginning
During the first day, buprenorphine is still active at your receptors. Many people feel only mild restlessness, yawning, sweating, or light anxiety. Some feel nearly normal. Do not mistake this calm for a sign that withdrawal will be easy. The absence of symptoms on day one is a pharmacological delay, not a guarantee.
Days 2 to 3: Withdrawal Becomes Obvious
By days two and three, most people begin to feel clearly unwell. The StatPearls buprenorphine reference describes this phase as dominated by flu-like symptoms, gastrointestinal upset, and nervous-system agitation. You may feel wired but exhausted: too tired to function, too uncomfortable to rest.
Common symptoms at this stage include:
- Muscle aches and body aches
- Nausea, vomiting, and diarrhea
- Sweating and chills
- Headache
- Insomnia and restlessness
- Anxiety and irritability
- Strong drug cravings
- Difficulty concentrating
Days 3 to 5: Peak Intensity
For most people who stop abruptly or taper quickly, days three to five bring the worst physical discomfort. Gastrointestinal symptoms, body aches, insomnia, and cravings can converge at once. This is also the highest-risk window for impulsive opioid use because the physical and emotional burden peaks together.
A Cochrane systematic review on buprenorphine for opioid withdrawal found that taper speed directly shapes this peak. A one-week taper tends to produce a sharper post-final-dose spike, while a four-week taper spreads symptoms more evenly. This is one of the strongest arguments for a slow, supervised taper over abrupt cessation.
Days 5 to 7: Physical Symptoms Start Easing
By the end of the first week, the most intense physical symptoms usually begin to lift. You may no longer feel acutely sick all day, but sleep remains poor, energy is low, and mood can swing unpredictably. Improvement at this stage is often nonlinear: mornings may feel tolerable while evenings bring renewed restlessness and cravings.
Week 2: Depression Takes Over
After the second week, depression often becomes the most prominent symptom. American Addiction Centers specifically notes that depression is the biggest symptom after week two. This transition from physical to psychological symptoms catches many people off guard. They expect withdrawal to be over once vomiting and chills stop, but the harder part for many is the emotional depletion that follows.
Weeks 3 to 4: Physical Withdrawal Mostly Resolves
Most acute physical symptoms have improved substantially by weeks three and four, but sleep, energy, mood, and cravings can remain unstable. American Addiction Centers states that most physical withdrawal symptoms generally subside after one month, though psychological dependence can remain. This is a clinically delicate period because the gap between outward functioning and inward distress can increase relapse risk if support decreases too soon.
Beyond One Month: Protracted Withdrawal and PAWS
Post-acute withdrawal syndrome, commonly called PAWS, refers to symptoms that continue after the obvious physical phase has passed. These are less about vomiting and chills and more about mood, motivation, sleep, and cravings. Episodic depression, anxiety, fatigue, poor concentration, and stress-triggered urges can persist for weeks or months. The ASAM national practice guideline recommends close monitoring even after buprenorphine is fully stopped, precisely because this phase carries real relapse risk.
How Long Do Withdrawal Symptoms Last from Suboxone?
The honest answer is: it depends on how you stop. A review of outpatient buprenorphine detoxification found that peak withdrawal often occurs after the dose drops below 2 mg or three to fifteen days after the final dose. This means the end of a taper is frequently where the real withdrawal begins, not the middle.
The table below summarizes the typical timeline.
| Timeframe | Typical Symptoms | What to Know |
| Hours 0 to 24 | Mild anxiety, yawning, sweating | Buprenorphine still active; symptoms minimal |
| Days 2 to 3 | Aches, chills, nausea, insomnia, cravings | First major acute phase |
| Days 3 to 5 | GI upset, body aches, peak discomfort | Highest relapse risk window |
| Days 5 to 7 | Fatigue, poor sleep, mood swings | Physical symptoms begin easing |
| Week 2 | Depression, low energy, cravings | Psychological symptoms become dominant |
| Weeks 3 to 4 | Cravings, anxiety, sleep disruption | Physical withdrawal mostly resolved |
| Month 1 and beyond | Episodic PAWS symptoms, stress cravings | Ongoing monitoring matters |
Duration is shaped by dose before stopping, how long you were on Suboxone, whether you tapered or quit abruptly, your mental health, pain conditions, and the strength of your recovery supports. A slow, individualized taper over months is the approach most consistent with ASAM clinical guidance and with the Cochrane evidence base.
Does Suboxone Have Withdrawal Symptoms Compared to Other Opioids?
Yes, and the comparison matters. Short-acting opioids like heroin or oxycodone typically produce faster-onset, sharper withdrawal that peaks within one to three days and largely resolves within about ten days. Suboxone withdrawal tends to be less explosive but more prolonged, with a delayed peak and a longer tail of mood, sleep, and craving symptoms. As Boulder Care’s clinical education resource puts it, tapering off Suboxone tends to be slower and longer than stopping short-acting opioids, even if the acute intensity is lower.
Less severe does not mean easy. The protracted psychological phase of Suboxone withdrawal is often what people find hardest to manage.
What Can Help with Suboxone Withdrawal
The most important thing you can do is not stop abruptly. The ASAM guideline is clear: buprenorphine tapering is a slow process, generally accomplished over several months, with close monitoring afterward. Abrupt cessation concentrates withdrawal, removes clinical oversight, and raises relapse and overdose risk.
Beyond a supervised taper, several evidence-informed measures can ease specific symptoms.
Clonidine or lofexidine are alpha-2 adrenergic agonists that reduce autonomic symptoms like sweating, chills, anxiety, and abdominal cramps. A Lancet review on opioid withdrawal treatment notes that clonidine can reduce noradrenergic symptoms but may not fully address subjective discomfort or sleep problems, so additional symptom treatment is often needed.
Loperamide for diarrhea, ondansetron or other antiemetics for nausea, and ibuprofen or acetaminophen for muscle aches are commonly used supportive medications. These appear in clinical withdrawal comfort protocols and are selected based on your medical history and other medications.
Hydroxyzine can help with anxiety and restlessness. Trazodone is often used for insomnia. Both require caution around sedation and drug interactions, especially if you are also using other medications that affect the central nervous system.
Hydration and basic self-care matter more than they sound. Sweating, diarrhea, and poor intake during withdrawal can leave you dehydrated and depleted. Oral rehydration, light meals, warm baths for aches, and protecting your sleep schedule all support recovery.
The most underused comfort measure is slowing the taper itself. If withdrawal becomes intolerable, the right response is usually to pause or reduce the pace of dose reduction, not to push through or add more medications. StatPearls recommends that clinicians consider slowing the taper and adding adjunctive agents when withdrawal symptoms emerge during dose reduction.
Naloxone should be available throughout and after tapering. Once buprenorphine is stopped, opioid tolerance falls. If you return to a previously tolerated opioid dose, overdose risk rises significantly. ASAM explicitly warns that patients who discontinue buprenorphine and resume opioid use face increased risk of overdose and death.
Counseling and peer support address the psychological phase that medications cannot fully reach. Depression, cravings, and stress intolerance during PAWS respond better to structured support than to waiting them out alone.
A Note on Continuing Treatment
It is worth saying plainly: stopping Suboxone is not automatically a better recovery outcome than staying on it. A randomized clinical trial published in JAMA Internal Medicine found that patients assigned to a buprenorphine taper had fewer opioid-negative urine samples, more illicit opioid use, and far lower trial completion rates than patients who continued maintenance. Only 11% of taper patients completed the trial compared with 66% of maintenance patients.
ASAM states there is no recommended time limit for buprenorphine treatment. If you are stable on Suboxone and your recovery is holding, the evidence does not support stopping simply because time has passed or because of outside pressure. Tapering should be a patient-centered, clinically supported decision made when recovery is genuinely stable, not an arbitrary goal.
If you do relapse after stopping, restarting buprenorphine is not failure. It is the evidence-backed response.
Getting Support for Suboxone Withdrawal
Withdrawal from Suboxone is manageable, but it is much safer and more tolerable with clinical support than without it. A slow, supervised taper with symptom monitoring, adjunct medications when needed, naloxone access, and ongoing counseling gives you the best chance of getting through withdrawal without relapse or overdose.
If you or someone you care about is navigating opioid use disorder or Suboxone withdrawal and needs structured support, reach out to the team at Thoroughbred Wellness and Recovery to learn about medical detox programs that can guide you through this process safely.
Give Us A Call 
